Warner Chilcott Stock Price, News & Analysis (NASDAQ:WCRX)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Warner Chilcott (NASDAQ:WCRX)

Warner Chilcott logoWarner Chilcott Public Limited Company is a specialty pharmaceutical company. The Company is focused on the women's healthcare, gastroenterology, dermatology and urology segments of the branded pharmaceuticals market, primarily in North America. The Company's hormonal contraceptive product offerings include LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the branded product in the United States hormonal contraception market, and LO LOESTRIN FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), its new oral contraceptive product, launched in January 2011, that offers women the lowest dosage of estrogen of any oral contraceptive available in the United States market. In October 2013, Actavis Inc acquired the entire share capital of Warner Chilcott PLC.

Receive WCRX News and Ratings via Email

Sign-up to receive the latest news and ratings for WCRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryPharmaceuticals
SectorHealthcare
SymbolNASDAQ:WCRX
CUSIPG9436810
WebN/A
Phone+353-1-8972000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Warner Chilcott (NASDAQ:WCRX) Frequently Asked Questions

What is Warner Chilcott's stock symbol?

Warner Chilcott trades on the NASDAQ under the ticker symbol "WCRX."

Who are some of Warner Chilcott's key competitors?

How do I buy Warner Chilcott stock?

Shares of Warner Chilcott can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Warner Chilcott?

Warner Chilcott's mailing address is Grand Canal Square, DUBLIN,, Ireland. The specialty pharmaceutical company can be reached via phone at +353-1-8972000.


MarketBeat Community Rating for Warner Chilcott (WCRX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  132 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about Warner Chilcott and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Warner Chilcott (NASDAQ:WCRX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Warner Chilcott (NASDAQ:WCRX) Earnings History and Estimates Chart

Earnings by Quarter for Warner Chilcott (NASDAQ:WCRX)

Warner Chilcott (NASDAQ WCRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2013Q2 2013$0.84$0.92$598.23 million$613.00 millionViewN/AView Earnings Details
5/10/2013Q1 2013$0.85$0.45$588.06 million$593.00 millionViewN/AView Earnings Details
2/22/2013Q4 2012$0.73$0.50$565.21 million$612.00 millionViewN/AView Earnings Details
11/9/2012Q312$0.77$0.99$595.96 million$606.00 millionViewN/AView Earnings Details
8/3/2012$0.79$1.03ViewN/AView Earnings Details
5/4/2012$0.93$1.16ViewN/AView Earnings Details
2/24/2012$0.90$0.95ViewN/AView Earnings Details
11/4/2011$0.90$0.89ViewN/AView Earnings Details
8/5/2011$0.89$0.93ViewN/AView Earnings Details
5/6/2011$0.82$1.04ViewN/AView Earnings Details
2/25/2011$0.74$0.81ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Warner Chilcott (NASDAQ:WCRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Warner Chilcott (NASDAQ:WCRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2013semiannual$0.253.33%5/29/20135/31/20136/14/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Warner Chilcott (NASDAQ WCRX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Warner Chilcott (NASDAQ WCRX) News Headlines

Source:
DateHeadline
Analyzing Warner Chilcott Plc (WCRX) and Eyegate Pharmaceuticals (EYEG)Analyzing Warner Chilcott Plc (WCRX) and Eyegate Pharmaceuticals (EYEG)
www.americanbankingnews.com - October 27 at 7:30 PM
Financial Comparison: Akorn (AKRX) and Warner Chilcott Plc (WCRX)Financial Comparison: Akorn (AKRX) and Warner Chilcott Plc (WCRX)
www.americanbankingnews.com - October 22 at 4:26 PM
$54 Million Settlement Resolving Whistleblower Claims Against CareCore National LLC Announced$54 Million Settlement Resolving Whistleblower Claims Against CareCore National LLC Announced
www.bizjournals.com - May 13 at 2:54 AM
BRIEF-Allergan announces tender offers by certain subsidiariesBRIEF-Allergan announces tender offers by certain subsidiaries
www.businessinsider.com - May 12 at 4:26 AM

SEC Filings

Warner Chilcott (NASDAQ:WCRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Warner Chilcott (NASDAQ:WCRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Warner Chilcott (NASDAQ WCRX) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.